Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: A randomized, phase 2 study
Russell SJ et al. Rheumatology (Oxford) 2018: key265. doi: 10.1093/rheumatology/key265
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.